Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro Christina Gavegnano a , b , Mervi Detorio a , b , Catherine Montero a , b , Alberto Bosque c , Vicente Planelles c and Raymond F. Schinazi a , b a Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA b Veterans Affairs Medical Center, Decatur, Georgia, USA c Department of Pathology, University of Utah, Salt Lake City, Utah, USA Next Section ABSTRACT The JAK-STAT pathway is activated in both macrophages and lymphocytes upon human immunodeficiency virus type 1 ...